Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Rider

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Glycoconjugate Journal|August 1, 1997
The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infectionC C Rider
Methods in Molecular Biology (Clifton, N.J.)|July 17, 1998
Analysis of glycosaminoglycans and proteoglycansC C Rider
Biochemical Society Transactions|May 20, 2006
Heparin/heparan sulphate binding in the TGF-beta cytokine superfamilyC C Rider
Biochemical Society Transactions|May 1, 1992
Sulphated glycoconjugates in the immune systemC C Rider
Journal of Neurochemistry|April 1, 1986
Apparent inhibition of ATP citrate lyase by L-glutamate in vitro is due to the presence of glutamine synthetaseC C Rider
Methods in Molecular Biology (Clifton, N.J.)|January 1, 1993
Analysis of sulfated polysaccharide conjugatesC C Rider
Biochemical Society Transactions|March 26, 2003
Interaction between glial-cell-line-derived neurotrophic factor (GDNF) and 2-O-sulphated heparin-related glycosaminoglycansC C Rider
Biochemical Society Transactions|May 20, 2006
Cytokines and proteoglycans: an introductory overviewB Mulloy, C C Rider
European Journal of Immunology|November 1, 1992
Selective and differential binding of interleukin (IL)-1 alpha, IL-1 beta, IL-2 and IL-6 to glycosaminoglycansL Ramsden, C C Rider
Glycobiology|March 14, 1998
Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4H A Harrop, C C Rider
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Glycoconjugate Journal|August 1, 1997
The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infectionC C Rider
Methods in Molecular Biology (Clifton, N.J.)|July 17, 1998
Analysis of glycosaminoglycans and proteoglycansC C Rider
Biochemical Society Transactions|May 20, 2006
Heparin/heparan sulphate binding in the TGF-beta cytokine superfamilyC C Rider
Biochemical Society Transactions|May 1, 1992
Sulphated glycoconjugates in the immune systemC C Rider
Journal of Neurochemistry|April 1, 1986
Apparent inhibition of ATP citrate lyase by L-glutamate in vitro is due to the presence of glutamine synthetaseC C Rider
Methods in Molecular Biology (Clifton, N.J.)|January 1, 1993
Analysis of sulfated polysaccharide conjugatesC C Rider
Biochemical Society Transactions|March 26, 2003
Interaction between glial-cell-line-derived neurotrophic factor (GDNF) and 2-O-sulphated heparin-related glycosaminoglycansC C Rider
Biochemical Society Transactions|May 20, 2006
Cytokines and proteoglycans: an introductory overviewB Mulloy, C C Rider
European Journal of Immunology|November 1, 1992
Selective and differential binding of interleukin (IL)-1 alpha, IL-1 beta, IL-2 and IL-6 to glycosaminoglycansL Ramsden, C C Rider
Glycobiology|March 14, 1998
Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4H A Harrop, C C Rider
Pageof 5